ORPREP Trademark

Trademark Overview


On Wednesday, April 22, 2020, a trademark application was filed for ORPREP with the United States Patent and Trademark Office. The USPTO has given the ORPREP trademark a serial number of 88883504. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 21, 2022. This trademark is owned by Leading BioSciences. The ORPREP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical formulations and preparations to treat acute and chronic health conditions related to gastrointestinal, inflammatory, metabolic, endocrine, immunological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, psychiatric, dermatological, and viral diseases and disorders; Pharmaceutical compositions in liquid form, namely, liquid compositions containing protease inhibitors, to treat health conditions, diseases, and disorders related to the gastrointestinal tract, gastrointestinal permeability, the gastrointestinal epithelial barrier, gastrointestinal inflammation, the gastrointestinal immune system, the microbiome, and the gut-brain axis; Pharmaceutical formulations and preparations to treat or prevent surgical complications and post-surgical complications; Pharmaceutical formulations and preparations to treat or prevent shock, namely, acute shock, cardiogenic shock, septic shock and hemorrhagic shock; Phar...
orprep

General Information


Serial Number88883504
Word MarkORPREP
Filing DateWednesday, April 22, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 21, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 25, 2020

Trademark Statements


Goods and ServicesPharmaceutical formulations and preparations to treat acute and chronic health conditions related to gastrointestinal, inflammatory, metabolic, endocrine, immunological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, psychiatric, dermatological, and viral diseases and disorders; Pharmaceutical compositions in liquid form, namely, liquid compositions containing protease inhibitors, to treat health conditions, diseases, and disorders related to the gastrointestinal tract, gastrointestinal permeability, the gastrointestinal epithelial barrier, gastrointestinal inflammation, the gastrointestinal immune system, the microbiome, and the gut-brain axis; Pharmaceutical formulations and preparations to treat or prevent surgical complications and post-surgical complications; Pharmaceutical formulations and preparations to treat or prevent shock, namely, acute shock, cardiogenic shock, septic shock and hemorrhagic shock; Pharmaceutical formulations and preparations to treat or prevent gastrointestinal tract injuries, ileus, and adhesions; Pharmaceutical formulations and preparations to treat or prevent multi-organ failure; Pharmaceutical formulations and preparations to treat or prevent health conditions, diseases, and disorders related to intestinal permeability, the microbiome, and the gut-brain axis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLeading BioSciences
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92008

Party NameLeading BioSciences
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92008

Trademark Events


Event DateEvent Description
Monday, November 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 18, 2022SOU EXTENSION 3 GRANTED
Monday, April 18, 2022SOU EXTENSION 3 FILED
Monday, April 18, 2022TEAS EXTENSION RECEIVED
Thursday, October 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 19, 2021SOU EXTENSION 2 GRANTED
Tuesday, October 19, 2021SOU EXTENSION 2 FILED
Tuesday, October 19, 2021TEAS EXTENSION RECEIVED
Wednesday, April 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 19, 2021SOU EXTENSION 1 GRANTED
Monday, April 19, 2021SOU EXTENSION 1 FILED
Monday, April 19, 2021TEAS EXTENSION RECEIVED
Tuesday, October 20, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 14, 2020ASSIGNED TO EXAMINER
Sunday, May 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 25, 2020NEW APPLICATION ENTERED IN TRAM